A search in PubMed database to identify studies analyzing the effects of anti-TNFalpha treatments on BMD and bone remodeling markers in RA patients has been able to identify four studies [29–32] in which BMD was either stabilized or increased at lumbar spine (up to 2.8%) or at hip (up to 13.1%). Here, TNF is linked to rheumatoid arthritis.